东方生物
(688298)
| 流通市值：39.07亿 | | | 总市值：39.07亿 |
| 流通股本：2.02亿 | | | 总股本：2.02亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,296,144,764.21 | 2,250,746,035.95 | 2,449,726,944.07 | 2,430,961,144.02 |
| 交易性金融资产 | 91,312,011.24 | 149,732,961.97 | 122,590,377.71 | 211,686,988.44 |
| 应收票据及应收账款 | 165,929,436.43 | 178,095,948.16 | 213,667,145.52 | 226,662,055.27 |
| 其中：应收票据 | 65,350 | 276,445 | 607,735 | 949,610 |
| 应收账款 | 165,864,086.43 | 177,819,503.16 | 213,059,410.52 | 225,712,445.27 |
| 预付款项 | 26,921,513.69 | 27,078,491.89 | 24,754,953.26 | 33,272,652.45 |
| 其他应收款合计 | 10,724,370.98 | 11,403,120.67 | 12,789,433.59 | 10,443,165.29 |
| 买入返售金融资产 | 0 | - | - | - |
| 存货 | 291,782,617.61 | 293,914,988.07 | 309,862,572.02 | 332,054,222.77 |
| 合同资产 | 0 | - | 0 | - |
| 一年内到期的非流动资产 | - | - | 0 | - |
| 其他流动资产 | 133,811,448.09 | 127,371,292.76 | 122,864,246.89 | 120,686,454.27 |
| 流动资产合计 | 3,016,626,162.25 | 3,038,342,839.47 | 3,256,255,673.06 | 3,365,766,682.51 |
| 非流动资产: | | | | |
| 债权投资 | 0 | - | 0 | - |
| 长期股权投资 | 70,219,304.22 | 17,152,335.96 | 17,624,764.18 | 18,339,883.43 |
| 其他非流动金融资产 | 31,609,608.94 | 30,294,872.75 | 30,230,070.24 | 30,183,130.55 |
| 固定资产 | 2,134,346,708.87 | 1,575,727,151.29 | 1,606,681,271.82 | 1,677,677,541.83 |
| 在建工程 | 469,769,655.52 | 1,021,385,088.21 | 1,009,683,512.16 | 1,112,445,250.68 |
| 使用权资产 | 21,977,505.68 | 24,978,708.63 | 28,231,207.51 | 37,104,514.65 |
| 无形资产 | 853,305,141.34 | 866,709,657.94 | 883,878,063.33 | 930,147,387.62 |
| 开发支出 | - | - | 0 | - |
| 商誉 | 0 | 0 | 0 | - |
| 长期待摊费用 | 35,923,520.01 | 36,750,161.61 | 42,120,277.54 | 47,881,124.88 |
| 递延所得税资产 | 228,385,384.08 | 250,729,013.15 | 256,115,208.13 | 272,743,992.7 |
| 其他非流动资产 | 30,518,851.67 | 30,981,074.83 | 8,125,779.35 | 15,434,091.52 |
| 非流动资产合计 | 3,876,055,680.33 | 3,854,708,064.37 | 3,882,690,154.26 | 4,141,956,917.86 |
| 资产总计 | 6,892,681,842.58 | 6,893,050,903.84 | 7,138,945,827.32 | 7,507,723,600.37 |
| 流动负债: | | | | |
| 短期借款 | 198,011,382.68 | 134,963,005.86 | 130,554,844.44 | 103,259,685 |
| 交易性金融负债 | 0 | 0 | 0 | - |
| 应付票据及应付账款 | 400,384,649.63 | 386,663,478.56 | 481,404,930.31 | 479,039,935.78 |
| 其中：应付票据 | 27,619,461.68 | 30,994,530.83 | 7,258,712.83 | 3,628,182 |
| 应付账款 | 372,765,187.95 | 355,668,947.73 | 474,146,217.48 | 475,411,753.78 |
| 预收款项 | 44,855.56 | 617,786.05 | 619,266.05 | - |
| 合同负债 | 26,930,360.56 | 27,716,122.16 | 37,524,600.66 | 33,251,251.15 |
| 应付职工薪酬 | 40,539,435.37 | 41,828,794.34 | 65,255,953.79 | 41,969,804.99 |
| 应交税费 | 7,466,300.1 | 5,376,819.29 | 12,181,140.54 | 6,200,832.43 |
| 其他应付款合计 | 95,471,940.06 | 82,968,859.43 | 92,385,589.02 | 106,516,944.59 |
| 一年内到期的非流动负债 | 122,002,428.9 | 121,446,825.78 | 11,120,079.78 | 15,110,511.29 |
| 其他流动负债 | 1,116,672.55 | 737,711 | 816,233.58 | 1,226,583.69 |
| 流动负债合计 | 891,968,025.41 | 802,319,402.47 | 831,862,638.17 | 786,575,548.92 |
| 非流动负债: | | | | |
| 长期借款 | 104,346,193 | 45,014,744.5 | 158,990,000 | 159,093,750 |
| 租赁负债 | 20,035,445.82 | 24,681,014.56 | 25,297,165.12 | 28,942,424.39 |
| 长期应付款 | 4,258,814.95 | 4,565,435.51 | 5,071,507.32 | 7,901,664.66 |
| 长期应付职工薪酬 | - | - | 0 | - |
| 预计负债 | 5,679,135 | 5,743,647 | 5,943,798 | 6,017,382 |
| 递延收益 | 25,663,767.72 | 25,842,325.36 | 26,062,461.58 | 26,324,176.38 |
| 递延所得税负债 | 18,990.5 | 8,607.72 | 43,066.17 | 54,067.22 |
| 其他非流动负债 | 0 | - | 0 | - |
| 非流动负债合计 | 160,002,346.99 | 105,855,774.65 | 221,407,998.19 | 228,333,464.65 |
| 负债合计 | 1,051,970,372.4 | 908,175,177.12 | 1,053,270,636.36 | 1,014,909,013.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 201,600,000 | 201,600,000 | 201,600,000 | 201,600,000 |
| 资本公积 | 397,975,635.81 | 397,975,635.81 | 397,885,635.81 | 397,885,635.81 |
| 减:库存股 | 326,942,031.65 | 326,942,031.65 | 326,942,031.65 | 326,942,031.65 |
| 其他综合收益 | 10,053,526.41 | 21,164,461.93 | 26,119,880.83 | 33,112,499.33 |
| 专项储备 | 263,572.77 | - | 0 | - |
| 盈余公积 | 84,000,000 | 84,000,000 | 84,000,000 | 84,000,000 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | 5,387,822,811.79 | 5,516,209,500.06 | 5,610,052,629.23 | 5,971,018,692.04 |
| 归属于母公司股东权益合计 | 5,754,773,515.13 | 5,894,007,566.15 | 5,992,716,114.22 | 6,360,674,795.53 |
| 少数股东权益 | 85,937,955.05 | 90,868,160.57 | 92,959,076.74 | 132,139,791.27 |
| 股东权益合计 | 5,840,711,470.18 | 5,984,875,726.72 | 6,085,675,190.96 | 6,492,814,586.8 |
| 负债和股东权益合计 | 6,892,681,842.58 | 6,893,050,903.84 | 7,138,945,827.32 | 7,507,723,600.37 |
| 公告日期 | 2026-08-29 | 2026-04-29 | 2026-04-29 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |